Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-Text (PDF)

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

Original Research Article


Development of Transdermal Ondansetron Hydrochloride for the Treatment of Chemotherapy-Induced Nausea and Vomiting 

Rajan Rajabalaya*, Ding Siok Chen and Sheba Rani Nakka David

Department of Pharmaceutical Technology, International Medical University, No. 126, Jalan Jalil Perkasa 19, Bukit Jalil 57000, Kuala Lumpur, Malaysia. 

*For correspondence: Email: rajan_rajabalaya@imu.edu.my  Tel: +60 327317210; Fax: +60 386567229 

Received:  6 July 2012                                                                                           Revised accepted: 17 April 2013

Tropical Journal of Pharmaceutical Research, June 2013; 12(3): 279-285

http://dx.doi.org/10.4314/tjpr.v12i3.1   

Abstract

 

Purpose: To to develop and evaluate matrix-type ondansetron hydrochloride (OS) transdermal patch for the treatment of chemotherapy-induced nausea and vomiting.

Methods: Transdermal patches were prepared by solvent casting method using ethyl cellulose and polyvinyl pyrrolidone as matrix materials, and dibutyl phthalate and dibutyl sebacate as plasticizers. The formulations were evaluated for patch thickness, tensile strength, moisture content, water absorption capacity and drug content. In vitro drug release and permeation of the patches were determined using a Franz diffusion cell.

Results: the tensile strength of all the formulations was in the range from 6.09 to 9.85 Mpa indicating that the [patches were strong. Maximum drug release in 8 h for dibutyl phthalate DBP and dibutyl sebacate DBS patches was 38.9  (DB6) and 53.4 % (DS3), respectively, which are significantly (p < 0.01) higher than the  lowest values of 17.8 (for DB1) and 35.0 % for (DS5), respectively. Drug release rate was 1.89 and 3.93 μg/h/cm2, respectively with DS2 and DB2 showing the highest permeation rate of 5.39 μg/h/cm2. Patches containing DBP followed Higuchi release model while patches formulated with DBS followed first order release kinetics.

Conclusion: Ondansetron matrix-type transdermal patches formulated with suitable amounts of chemical enhancers for better patient compliance are feasible.

 

Keywords: Ondansetron hydrochloride, Chemical enhancers, Plasticizers, Dibutyl phthalate, Dibutyl sebacate, Permeation, Patch.

Copyright@2002-2010. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net